Blast Crisis of Chronic Myelocytic Leukemia that Was Difficult to Differentiate from Ph<sup>+</sup> Acute Lymphoblastic Leukemia

DOI PubMed 10 References
  • KANEKO Junko
    The Hematology Division, School of Medicine Iwate Medical University
  • UCHIYAMA Toshiyuki
    The Hematology Division, School of Medicine Iwate Medical University
  • OYAKE Tatsuo
    The Hematology Division, School of Medicine Iwate Medical University
  • ENOMOTO Sanae
    The Hematology Division, School of Medicine Iwate Medical University
  • ONO Yohko
    The Hematology Division, School of Medicine Iwate Medical University
  • SUGAWARA Takeshi
    The Hematology Division, School of Medicine Iwate Medical University
  • NUMAOKA Hideharu
    The Hematology Division, School of Medicine Iwate Medical University
  • SHIMOSEGAWA Kenji
    The Hematology Division, School of Medicine Iwate Medical University
  • ITOH Shigeki
    The Hematology Division, School of Medicine Iwate Medical University
  • MURAI Kazunori
    The Hematology Division, School of Medicine Iwate Medical University
  • ISHIDA Yoji
    The Hematology Division, School of Medicine Iwate Medical University
  • KURIYA Shin-ichiro
    The Hematology Division, School of Medicine Iwate Medical University

Bibliographic Information

Other Title
  • 慢性骨髄性白血病非定型例の急性転化と推測されるフィラデルフィア染色体陽性白血病

Search this article

Description

We encountered a 44-year-old woman with suspected chronic myelocytic leukemia (CML) in the acute phase that was difficult to be differentiate from Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL). At disease onset, her bone marrow showed an increase in blasts that were negative for myeloperoxydase (MPO) and Positive for CD10, 19, 34, and HLA·DR. Standard type Ph was detected by chromosome analysis, and both major and minor BCR/ABL m-RNA were detected by reverse-transcriptase polymerase chain reaction (RT-PCR) methods. Neutrophil alkaliphosphatase (NAP) score was normal, and neither eosinophilia nor basophilia was observed in peripheral blood. Under a presumptive diagnosis of Ph-positive ALL (L2), the patient was given AdVP (doxorubicin, vincristine, and prednisolone) therapy followed by a regimen of LMVP (L-asparaginase, mitoxantrone, and VP), and obtained a complete remission 2 months later. At that time, FISH analyses of her bone marrow and blood cells no longer detected bone marrow Ph or BCR/ABL fusion gene. A month later, however, the leukemia relapsed with an increase in MPO-positive blasts in bone marrow, and the patient died soon thereafter. We finally concluded that her leukemia was not Ph-positive ALL, but CML in the acute phase at disease onset.

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 40 (11), 1174-1180, 1999

    The Japanese Society of Hematology

References(10)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top